Recce Pharma (ASX:RCE) kicks-off dosing for next cohort of UTI trial Posted on March 13, 2024September 25, 2024 by recce_com Recce Pharma (ASX:RCE) kicks-off dosing for next cohort of UTI trial
Recce Pharmaceuticals secures AUD$11.18M from Endpoints Capital Posted on March 13, 2024September 25, 2024 by recce_com Recce Pharmaceuticals secures AUD$11.18M from Endpoints Capital
Biotech around the World: The Low-Down on the Land Down Under Posted on March 3, 2024September 25, 2024 by recce_com Biotech around the World: The Low-Down on the Land Down Under
BioBoss Podcast – CEO James Graham Posted on February 29, 2024September 25, 2024 by recce_com BioBoss Podcast – CEO James Graham
Recce Pharmaceuticals leads the way in collaborative Anti-Infective research Posted on February 27, 2024September 25, 2024 by recce_com Recce Pharmaceuticals leads the way in collaborative Anti-Infective research
Recce Pharmaceuticals wins safety approval to expand wound infection trial Posted on February 26, 2024September 25, 2024 by recce_com Recce Pharmaceuticals wins safety approval to expand wound infection trial
Scrip Asks…What Does 2024 Hold For Biopharma? Part 6: Therapeutic Area Advances Posted on February 15, 2024September 25, 2024 by recce_com Scrip Asks…What Does 2024 Hold For Biopharma? Part 6: Therapeutic Area Advances
Recce Pharmaceuticals Establishes Strategic Partnership in South-East Asia to Accelerate Clinical Program Posted on February 8, 2024September 25, 2024 by recce_com Recce Pharmaceuticals Establishes Strategic Partnership in South-East Asia to Accelerate Clinical Program
Recce Pharmaceuticals teams with leading Indonesian biomed company for anti-infective push Posted on February 6, 2024September 25, 2024 by recce_com Recce Pharmaceuticals teams with leading Indonesian biomed company for anti-infective push
Recce Pharmaceuticals to expand diabetes foot infection trial as results prove strong Posted on January 28, 2024September 25, 2024 by recce_com Recce Pharmaceuticals to expand diabetes foot infection trial as results prove strong
